Found: 14
Select item for more details and to access through your institution.
AAV Mediated Delivery of Myxoma Virus M013 Gene Protects the Retina against Autoimmune Uveitis.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 12, p. 2082, doi. 10.3390/jcm8122082
- By:
- Publication type:
- Article
Individual and Synergistic Anti-Coronavirus Activities of SOCS1/3 Antagonist and Interferon α1 Peptides.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.902956
- By:
- Publication type:
- Article
Noncanonical IFN Signaling: Mechanistic Linkage of Genetic and Epigenetic Events.
- Published in:
- Mediators of Inflammation, 2016, p. 1, doi. 10.1155/2016/9564814
- By:
- Publication type:
- Article
Disparate viral pandemics from COVID19 to monkeypox and beyond: a simple, effective and universal therapeutic approach hiding in plain sight.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1208828
- By:
- Publication type:
- Article
A C-terminal peptide from type I interferon protects the retina in a mouse model of autoimmune uveitis.
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0227524
- By:
- Publication type:
- Article
Noncanonical IFN Signaling, Steroids, and STATs: A Probable Role of V-ATPase.
- Published in:
- Mediators of Inflammation, 2019, p. 1, doi. 10.1155/2019/4143604
- By:
- Publication type:
- Article
Suppressor of cytokine signaling 3-derived peptide as a therapeutic for inflammatory and oxidative stress-induced damage to the retina.
- Published in:
- Molecular Vision, 2023, v. 29, p. 338
- By:
- Publication type:
- Article
Repurposing an orally available drug for the treatment of geographic atrophy.
- Published in:
- Molecular Vision, 2016, v. 22, p. 1
- By:
- Publication type:
- Article
SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.582102
- By:
- Publication type:
- Article
Corneal application of SOCS1/3 peptides for the treatment of eye diseases mediated by inflammation and oxidative stress.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1416181
- By:
- Publication type:
- Article
A SOCS1/3 Antagonist Peptide Protects Mice Against Lethal Infection with Influenza A Virus.
- Published in:
- Frontiers in Immunology, 2015, v. 6, p. 1, doi. 10.3389/fimmu.2015.00574
- By:
- Publication type:
- Article
SOCS1 mimetics and antagonists: a complementary approach to positive and negative regulation of immune function.
- Published in:
- Frontiers in Immunology, 2015, v. 6, p. 1, doi. 10.3389/fimmu.2015.00183
- By:
- Publication type:
- Article
Regulation of interferon gamma signaling by suppressors of cytokine signaling and regulatory T cells.
- Published in:
- Frontiers in Immunology, 2013, v. 4, p. 1, doi. 10.3389/fimmu.2013.00469
- By:
- Publication type:
- Article
IFN signaling: how a non-canonical model led to the development of IFN mimetics.
- Published in:
- Frontiers in Immunology, 2013, v. 4, p. 1, doi. 10.3389/fimmu.2013.00202
- By:
- Publication type:
- Article